The Early Reversibility of Rocuronium After Different Doses of Neostigmine

NCT00001520 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

60

Enrollment

NIH

Sponsor class

Conditions

Paralysis

Interventions

DRUG: neostigmine

Sponsor

National Institutes of Health Clinical Center (CC)